Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02960412
Other study ID # Pro00026976
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date May 1, 2017
Est. completion date June 30, 2018

Study information

Verified date March 2019
Source University of South Florida
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates if administration of IV furosemide leads to expedited confirmation of ureteral patency when compared to placebo (IV saline) in routine cystoscopy performed after urogynecologic surgery.


Description:

Cystoscopy is performed routinely after urogynecologic surgery to ensure there was no injury to the urinary tract (urethra, bladder, or ureters). In order to confirm that no damage occurred to the ureters, a jet of urine must be visualized from each ureteral opening.

The time it takes to confirm this ureteral patency is variable and some sources suggest using furosemide to decrease the time it takes to see these jets. This study will evaluate what effect, if any, this medicine has on time to confirming ureteral patency.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date June 30, 2018
Est. primary completion date March 31, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Undergoing any urogynecologic surgery

- No allergy or contraindication to receiving furosemide

- Normal Creatinine/glomerular filtration rate

Exclusion Criteria:

- Unable to consent, including if non English speaking

- Allergy or contraindication to receiving furosemide

- Intraoperative injury to the lower urinary tract

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
furosemide
10mg lasix given intraoperatively
Normal Saline
Normal saline given intraoperatively as placebo

Locations

Country Name City State
United States Tampa General Hospital Tampa Florida

Sponsors (1)

Lead Sponsor Collaborator
University of South Florida

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary time to ureteral patency time to confirmation of ureteral patency in seconds intra-operative
Secondary adverse effects from furosemide administration immediately post operative (1-3 days post operatively)
See also
  Status Clinical Trial Phase
Recruiting NCT00563069 - Premedication With Oral Midazolam in Patients Undergoing Rigid Cystoscopy: A Randomized, Double-blind, Placebo-controlled Trial N/A
Not yet recruiting NCT04019756 - IDENTIFICATION OF URINARY MICROBIOTE IN PATIENTS WITH DIAGNOSTIC-RELATED CYSTOSCOPY
Active, not recruiting NCT03138824 - Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC N/A
Recruiting NCT05415631 - Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence
Recruiting NCT06342193 - Effect of Virtual Reality Glasses on Anxiety During Cystoscopy: A Randomised Controlled Trial N/A
Completed NCT04595344 - Effects of Listening to Binaural Beats on Anxiety and Pain Scores in Males Undergoing Cystoscopy and Stent Removal N/A
Completed NCT05190939 - The Use of Dye-less Cystoscopy in Assessing Urinary Tract Integrity During Hysterectomy N/A
Completed NCT06235853 - Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer
Active, not recruiting NCT03347721 - Does Lidocaine Gel Decrease Pain Perception in Women Undergoing Diagnostic Flexible Cystoscopy Phase 4
Not yet recruiting NCT04440579 - Utilization of PTNS During Office-Based Cystoscopy N/A
Completed NCT04829461 - Effectiveness of Ambu® aScope™ 4 Cysto With the aView™ 2 Advance for Flexible Cystoscopy N/A
Completed NCT02424149 - Phenazopyridine for Confirmation of Ureteral Patency N/A
Completed NCT04413175 - Effects of Music Therapy on Procedural Pain, Anxiety and Comfort Level During Cystoscopy N/A
Active, not recruiting NCT02715648 - Using Phenazopyridine for In-office Cystoscopy N/A